BB BIOTECH AG 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:34 pm Sale | 2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | BB BIOTECH AG | 0 0.000% | -2,680,283 (Position Closed) | Filing |
| 2021-02-12 4:51 pm Unchanged | 2020-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | BB BIOTECH AG | 2,680,283 7.200% | 0 (Unchanged) | Filing |
| 2020-02-14 2:45 pm Sale | 2019-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | BB BIOTECH AG | 2,680,283 7.200% | -185,558 (-6.47%) | Filing |